Apyx Medical Story

APYX -- USA Stock

USD 9.74 0.10 1.04%

Macroaxis Story

As many millenniums are excited about healthcare space, it is only fair to break down Apyx Medical Corp. What exactly are Apyx Medical shareholders getting in May? Is the firm valuation sustainable? Here I will cover a perspective on valuation of Apyx Medical to give you a better outlook on taking a position in this stock.

Published over two weeks ago

View all stories for Apyx Medical | View All Stories

Is Apyx Medical (NASDAQ:APYX) ready for a correction?

This firm currently holds 1.03 M in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest Apyx Medical is not taking enough advantage from borrowing.

We provide trade advice to complement the prevailing expert consensus on Apyx Medical Corp. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time.

Is Apyx Medical (NASDAQ:APYX) ready for a correction?

We determine the current worth of Apyx Medical Corp using both absolute as well as relative valuation methodologies to arrive at its intrinsic value. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Apyx Medical Corp based exclusively on its fundamental and basic technical indicators. By analyzing Apyx Medical's financials, quarterly and monthly indicators, and related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Apyx Medical's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Apyx Medical. We calculate exposure to Apyx Medical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Apyx Medical's related companies.

Apyx Medical Corp Investment Alerts

Apyx Medical investment alerts and warnings help investors to get more proficient at understanding not only critical technical and fundamental signals but also the significant portfolio-centered indicators. These indicators include beta, alpha, and other risk-related measures that will help you in monitoring Apyx Medical Corp performance across your portfolios.Please check all investment alerts for Apyx Medical

Apyx Medical Valuation Ratios as Compared to Competition

Our valuation model uses many indicators to compare Apyx Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Apyx Medical competition to find correlations between indicators driving the intrinsic value of Apyx Medical.

How Apyx Medical utilizes its cash?

To perform a cash flow analysis of Apyx Medical, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Apyx Medical is receiving and how much cash it distributes out in a given period. The Apyx Medical cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.

Apyx Medical Net Cash Flow from Operations is fairly stable at the moment as compared to the past year. Apyx Medical reported Net Cash Flow from Operations of (16.07 Million) in 2020

Exercise of in-the-money or at-the-money derivative position by Lawrence Waldman of 7500 shares of Apyx Medical

Legal trades by Apyx Medical insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:

Apyx Medical insider trading alert for exercise of stock option (option to buy) by Lawrence Waldman, the corporate stakeholder, on 8th of March 2021. This event was filed by Apyx Medical Corp with SEC on 2021-03-08. Statement of changes in beneficial ownership - SEC Form 4 [view details]

Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

Details

The current price rise of Apyx Medical Corp could raise concerns from investors as the firm it trading at a share price of 9.66 on 237,082 in volume. The company directors and management may have good odds in positioning the firm resources to exploit market volatility in May. The stock standard deviation of daily returns for 30 days investing horizon is currently 4.76. This high volatility is attributed to the latest market swings and not so good earnings reports for some of the Apyx Medical partners.

	2018	2019	2020	2021 (projected)
Interest Expense	104 K	8 K	7.2 K	7.39 K
Gross Profit	10.83 M	19.09 M	21.96 M	17.62 M

Interest Expense Gross Profit

Margins Breakdown

Apyx Medical profit margins show the degree to which it makes money. Margin indicators are used not only by investors but also by creditors or Apyx Medical itself as indicators of financial health and management effectiveness. Please look more closely at the different varieties of Apyx Medical profit margins.

	EBITDA Margin	(0.8)
	Gross Margin	0.7
	Profit Margin	(0.82)

Apyx Medical Average Assets is increasing over the last 8 years. Also, Apyx Medical Average Equity is fairly stable at the moment.

Analysis of Apyx Medical Corp

Current semi variance is at 12.09.

As of the 31st of March, Apyx Medical shows the Downside Deviation of 3.73, risk adjusted performance of 0.1168, and Mean Deviation of 3.49. Apyx Medical Corp technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyzed and interpolated nineteen technical drivers for Apyx Medical Corp, which can be compared to its rivals. Please confirm Apyx Medical Corp jensen alpha and semi variance to decide if Apyx Medical Corp is priced correctly, providing market reflects its regular price of 9.66 per share. Given that Apyx Medical has jensen alpha of 0.5857, we suggest you to validate Apyx Medical Corp's prevailing market performance to make sure the company can sustain itself at a future point.

Our Final Takeaway

While some companies under the medical devices industry are still a bit expensive, Apyx Medical may offer a potential longer-term growth to investors. While some investors may not share our view we believe it may be a good time to exit Apyx Medical as the risk-reward trade off is not appealing enough to hold a position. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Apyx Medical.

About Contributor

Raphi Shpitalnik is a Junior Member of Macroaxs Editorial Board. Raphael is a young entrepreneur who joined Macroaxis on a part-time base at the beginning of the pandemic and eventually acquired a real test for investing and fintech. He likes to analyze different equity instruments across a wide range of industries, focusing primarily on consumer products, sports, fintech, cannabis, and AI. View Profile

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Apyx Medical Corp. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2021 Macroaxis LLC